These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 27385055)

  • 1. Improving the quality of life and psychological well-being of recently diagnosed multiple sclerosis patients: preliminary evaluation of a group-based cognitive behavioral intervention.
    Calandri E; Graziano F; Borghi M; Bonino S
    Disabil Rehabil; 2017 Jul; 39(15):1474-1481. PubMed ID: 27385055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of a group-based cognitive behavioral therapy on people with multiple sclerosis: a randomized controlled trial.
    Graziano F; Calandri E; Borghi M; Bonino S
    Clin Rehabil; 2014 Mar; 28(3):264-74. PubMed ID: 24013269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coping strategies and adjustment to multiple sclerosis among recently diagnosed patients: the mediating role of sense of coherence.
    Calandri E; Graziano F; Borghi M; Bonino S
    Clin Rehabil; 2017 Oct; 31(10):1386-1395. PubMed ID: 28933614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring change in a group-based psychological intervention for multiple sclerosis patients.
    Borghi M; Bonino S; Graziano F; Calandri E
    Disabil Rehabil; 2018 Jul; 40(14):1671-1678. PubMed ID: 28355925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health-related quality of life in patients with relapsing-remitting multiple sclerosis treated with subcutaneous interferon β-1a in Iran.
    Pakdaman H; Amini Harandi A; Gharagozli K; Abbasi M; Tabassi A; Ashrafi F; Ghaffarpor M; Sharifi S; Delavar Kasmae H; Assarzadegan F; Arabahmadi M; Behnam B
    Int J Neurosci; 2017 Jun; 127(6):501-507. PubMed ID: 27279451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved self-efficacy in persons with relapsing remitting multiple sclerosis after an intensive social cognitive wellness program with participation of support partners: a 6-months observational study.
    Jongen PJ; Ruimschotel R; Heerings M; Hussaarts A; Duyverman L; van der Zande A; Valkenburg-Vissers J; Wolper H; van Droffelaar M; Lemmens W; Donders R; Visser LH
    Health Qual Life Outcomes; 2014 Mar; 12():40. PubMed ID: 24646061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The psychosocial and cognitive impact of longstanding 'benign' multiple sclerosis.
    Sayao AL; Bueno AM; Devonshire V; Tremlett H;
    Mult Scler; 2011 Nov; 17(11):1375-83. PubMed ID: 21677023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intensive social cognitive treatment (can do treatment) with participation of support partners in persons with relapsing remitting multiple sclerosis: observation of improved self-efficacy, quality of life, anxiety and depression 1 year later.
    Jongen PJ; Heerings M; Ruimschotel R; Hussaarts A; Duyverman L; van der Zande A; Valkenburg-Vissers J; van Droffelaar M; Lemmens W; Donders R; Visser LH
    BMC Res Notes; 2016 Jul; 9():375. PubMed ID: 27473375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropsychological rehabilitation has beneficial effects on perceived cognitive deficits in multiple sclerosis during nine-month follow-up.
    Rosti-Otajärvi E; Mäntynen A; Koivisto K; Huhtala H; Hämäläinen P
    J Neurol Sci; 2013 Nov; 334(1-2):154-60. PubMed ID: 24011606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of health anxiety in patients with relapsing remitting multiple sclerosis: Misperception, misattribution and quality of life.
    Hayter AL; Salkovskis PM; Silber E; Morris RG
    Br J Clin Psychol; 2016 Nov; 55(4):371-386. PubMed ID: 26806805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of an intensive 3-day social cognitive treatment (can do treatment) on control self-efficacy in patients with relapsing remitting multiple sclerosis and low disability: A single-centre randomized controlled trial.
    Jongen PJ; van Mastrigt GA; Heerings M; Visser LH; Ruimschotel RP; Hussaarts A; Duyverman L; Valkenburg-Vissers J; Cornelissen J; Bos M; van Droffelaar M; Donders R
    PLoS One; 2019; 14(10):e0223482. PubMed ID: 31600271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurological disability, psychological distress, and health-related quality of life in MS patients within the first three years after diagnosis.
    Kern S; Schrempf W; Schneider H; Schultheiss T; Reichmann H; Ziemssen T
    Mult Scler; 2009 Jun; 15(6):752-8. PubMed ID: 19482864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationships among depressive symptoms, benefit-finding, optimism, and positive affect in multiple sclerosis patients after psychotherapy for depression.
    Hart SL; Vella L; Mohr DC
    Health Psychol; 2008 Mar; 27(2):230-8. PubMed ID: 18377142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determinants of quality of life in relapsing-remitting and progressive multiple sclerosis.
    Yalachkov Y; Soydaş D; Bergmann J; Frisch S; Behrens M; Foerch C; Gehrig J
    Mult Scler Relat Disord; 2019 May; 30():33-37. PubMed ID: 30735970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of group cognitive rehabilitation therapy in multiple sclerosis.
    Mani A; Chohedri E; Ravanfar P; Mowla A; Nikseresht A
    Acta Neurol Scand; 2018 Jun; 137(6):589-597. PubMed ID: 29411360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of motor-motor and motor-cognitive tasks on balance in patients with multiple sclerosis.
    Mercan F; Kara B; Tiftikcioglu BI; Mercan E; Sertpoyraz FM
    Mult Scler Relat Disord; 2016 May; 7():85-91. PubMed ID: 27237766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An intensive social cognitive program (can do treatment) in people with relapsing remitting multiple sclerosis and low disability: a randomized controlled trial protocol.
    Jongen PJ; Heerings M; Ruimschotel R; Hussaarts A; Evers S; Duyverman L; Valkenburg-Vissers J; Cornelissen J; Bos M; van Droffelaar M; Lemmens WA; Donders R; van der Zande A; Visser LH
    BMC Neurol; 2016 May; 16():81. PubMed ID: 27234001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-fat, plant-based diet in multiple sclerosis: A randomized controlled trial.
    Yadav V; Marracci G; Kim E; Spain R; Cameron M; Overs S; Riddehough A; Li DK; McDougall J; Lovera J; Murchison C; Bourdette D
    Mult Scler Relat Disord; 2016 Sep; 9():80-90. PubMed ID: 27645350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Young adults' adjustment to a recent diagnosis of multiple sclerosis: The role of identity satisfaction and self-efficacy.
    Calandri E; Graziano F; Borghi M; Bonino S
    Disabil Health J; 2019 Jan; 12(1):72-78. PubMed ID: 30093321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Health-related quality of life as an independent predictor of long-term disability for patients with relapsing-remitting multiple sclerosis.
    Baumstarck K; Pelletier J; Butzkueven H; Fernández O; Flachenecker P; Idiman E; Stecchi S; Boucekine M; Auquier P;
    Eur J Neurol; 2013 Jun; 20(6):907-14, e78-9. PubMed ID: 23347258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.